{"transactions":[{"id":1373109,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86252,"kind":"organization","name":"Boxer Capital Management, LLC","position":1,"cik":"0002018299","reported_name":"Boxer Capital Management, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-11-08T02:30:23.000Z","date":"2024-11-06","kind":"sale","planned":false,"acquired":false,"shares":3080000,"price":3.14,"value":9671200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.3955, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held indirectly by Boxer Capital Management, LLC (\"BCM\") as the investment manager of an account holding such securities. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Mr. Davis is the Managing Member of BCM and has voting and dispositive power over securities beneficially owned by BCM, but disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, if any."}],"balance_after":3610642,"source":{"system":"sec-edgar","filing":"0000895345-24-000548","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2018299/000089534524000548/form4.xml","form_type":"4"}},{"id":1380746,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86252,"kind":"organization","name":"Boxer Capital Management, LLC","position":1,"cik":"0002018299","reported_name":"Boxer Capital Management, LLC","relationship":{"other":true,"other_text":"See remarks."}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks."}}],"security":"Common Stock","published_at":"2024-10-28T10:59:22.000Z","date":"2024-10-25","kind":"sale","planned":false,"acquired":false,"shares":633000,"price":6.87,"value":4348710.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.8500 to $6.8700, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held indirectly by Boxer Capital Management, LLC (\"BCM\") as the investment manager of an account holding such securities. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Mr. Davis is the Managing Member of BCM and has voting and dispositive power over securities beneficially owned by BCM, but disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, if any."}],"balance_after":6690642,"source":{"system":"sec-edgar","filing":"0000895345-24-000485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2018299/000089534524000485/form4.xml","form_type":"4"}},{"id":1382425,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86252,"kind":"organization","name":"Boxer Capital Management, LLC","position":1,"cik":"0002018299","reported_name":"Boxer Capital Management, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-10-24T01:31:42.000Z","date":"2024-10-22","kind":"sale","planned":false,"acquired":false,"shares":250000,"price":6.78,"value":1695000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.7100 to $6.9050, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held indirectly by Boxer Capital Management, LLC (\"BCM\") as the investment manager of an account holding such securities. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Mr. Davis is the Managing Member of BCM and has voting and dispositive power over securities beneficially owned by BCM, but disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, if any."}],"balance_after":7323642,"source":{"system":"sec-edgar","filing":"0000895345-24-000470","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2018299/000089534524000470/form4.xml","form_type":"4"}},{"id":1382424,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86252,"kind":"organization","name":"Boxer Capital Management, LLC","position":1,"cik":"0002018299","reported_name":"Boxer Capital Management, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-10-24T01:31:42.000Z","date":"2024-10-21","kind":"sale","planned":false,"acquired":false,"shares":625000,"price":7.05,"value":4406250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0018 to $7.2372, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held indirectly by Boxer Capital Management, LLC (\"BCM\") as the investment manager of an account holding such securities. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Mr. Davis is the Managing Member of BCM and has voting and dispositive power over securities beneficially owned by BCM, but disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, if any."}],"balance_after":7573642,"source":{"system":"sec-edgar","filing":"0000895345-24-000470","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2018299/000089534524000470/form4.xml","form_type":"4"}},{"id":1383081,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":86252,"kind":"organization","name":"Boxer Capital Management, LLC","position":1,"cik":"0002018299","reported_name":"Boxer Capital Management, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Pre-Funded Warrant (right to purchase)","published_at":"2024-10-23T00:49:28.000Z","date":"2024-10-18","kind":"grant","planned":false,"acquired":true,"shares":2000000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, Boxer Capital, LLC (\"Boxer\") entered into an exchange agreement with the Issuer, pursuant to which Boxer agreed to exchange 2,000,000 shares of the Issuer's Common Stock for a pre-funded warrant to purchase up to 2,000,000 shares of Common Stock (the \"Pre-Funded Warrant\").  The Pre-Funded Warrant was issued on October 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, Boxer Capital, LLC (\"Boxer\") entered into an exchange agreement with the Issuer, pursuant to which Boxer agreed to exchange 2,000,000 shares of the Issuer's Common Stock for a pre-funded warrant to purchase up to 2,000,000 shares of Common Stock (the \"Pre-Funded Warrant\").  The Pre-Funded Warrant was issued on October 22, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Pre-Funded Warrant has no expiration date and is exercisable at any time after the date of issuance. A holder of the Pre-Funded Warrant may not exercise the Pre-Funded Warrant if the holder, together with other persons whose beneficial ownership is aggregated for purposes of Section 13 or Section 16 under the Securities Exchange Act of 1934, as amended, would beneficially own more than 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrant has no expiration date and is exercisable at any time after the date of issuance. A holder of the Pre-Funded Warrant may not exercise the Pre-Funded Warrant if the holder, together with other persons whose beneficial ownership is aggregated for purposes of Section 13 or Section 16 under the Securities Exchange Act of 1934, as amended, would beneficially own more than 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned indirectly by Boxer Capital Management, LLC (\"BCM\") as the investment manager of Boxer. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":2705280,"derivative":{"exercise_price":0.001,"underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0000895345-24-000458","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2018299/000089534524000458/form4.xml","form_type":"4"}},{"id":1383080,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":86252,"kind":"organization","name":"Boxer Capital Management, LLC","position":1,"cik":"0002018299","reported_name":"Boxer Capital Management, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-10-23T00:49:28.000Z","date":"2024-10-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, Boxer Capital, LLC (\"Boxer\") entered into an exchange agreement with the Issuer, pursuant to which Boxer agreed to exchange 2,000,000 shares of the Issuer's Common Stock for a pre-funded warrant to purchase up to 2,000,000 shares of Common Stock (the \"Pre-Funded Warrant\").  The Pre-Funded Warrant was issued on October 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, Boxer Capital, LLC (\"Boxer\") entered into an exchange agreement with the Issuer, pursuant to which Boxer agreed to exchange 2,000,000 shares of the Issuer's Common Stock for a pre-funded warrant to purchase up to 2,000,000 shares of Common Stock (the \"Pre-Funded Warrant\").  The Pre-Funded Warrant was issued on October 22, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned indirectly by Boxer Capital Management, LLC (\"BCM\") as the investment manager of Boxer. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":4448359,"source":{"system":"sec-edgar","filing":"0000895345-24-000458","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2018299/000089534524000458/form4.xml","form_type":"4"}}]}